The Valley Desk

NCT06111235 · Interventional trial

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Overall registry status Active not recruiting

Phase 3

Conditions Bladder Cancer, Non Muscle Invasive Bladder Cancer, Urologic Cancer, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov